Product Information
LIDOCAINE 2% VISCOUS SOLN is a generic product labeled by PAI Holdings LLC, priced at $0.0825 per ML under NDC 00121095003. Its NADAC has been published 112 times since Aug 14, 2024.
FDA first approved this application on Feb 20, 2024. Its Orange Book therapeutic-equivalence code is AT.
Strength
20 mg/mL
Manufacturer
PAI Holdings LLCNDC
00121095003
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LIDOCAINE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA218138FDA Approved
2/20/2024
TE Code
AT
On Market Since
2/20/2024
Pharmacological Classes
Price Statistics
The NADAC for LIDOCAINE 2% VISCOUS SOLN has been published 112 times since Aug 14, 2024, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0825 per ML |
|---|---|
| All-time high | $0.1070 (May 14, 2025) |
| All-time low | $0.0792 (Apr 22, 2026) |
| 52-week high | $0.0989 |
| 52-week low | $0.0792 |
| Median price | $0.0937 |
| Average price | $0.0922 |
| Largest weekly change | -14.2% (Nov 20, 2024) |
| Weeks tracked | 112 |
| Tracking since | Aug 14, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
PAI Holdings LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Lidocaine Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Amide Local Anesthetic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LIDOCAINE 2% VISCOUS SOLN?
The current National Average Drug Acquisition Cost (NADAC) for LIDOCAINE 2% VISCOUS SOLN, manufactured by PAI Holdings LLC, is $0.0825 per ML (NDC 00121095003), effective Sep 30, 2026.
How has the price of LIDOCAINE 2% VISCOUS SOLN changed over time?
Over the history we have for it, the NADAC for LIDOCAINE 2% VISCOUS SOLN has held within roughly two percent of its current level. It has been tracked across 112 weekly CMS publications since Aug 14, 2024.
What are the highest and lowest recorded NADAC prices for LIDOCAINE 2% VISCOUS SOLN?
Since Aug 14, 2024, the NADAC for LIDOCAINE 2% VISCOUS SOLN has ranged from a low of $0.0792 (Apr 22, 2026) to a high of $0.1070 (May 14, 2025), with a median of $0.0937 per ML.
Are there cheaper alternatives to LIDOCAINE 2% VISCOUS SOLN?
3 manufacturers publish a NADAC-priced product with the same active ingredient and strength as LIDOCAINE 2% VISCOUS SOLN in a comparable dosage form, but none are currently priced below it.
Who manufactures LIDOCAINE 2% VISCOUS SOLN?
LIDOCAINE 2% VISCOUS SOLN (NDC 00121095003) is labeled by PAI Holdings LLC, and CMS classifies it as a generic product.